VEGFB Antikörper (AA 22-207)
Kurzübersicht für VEGFB Antikörper (AA 22-207) (ABIN7175368)
Target
Alle VEGFB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 22-207
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Vascular endothelial growth factor B protein (22-207AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VEGFB (Vascular Endothelial Growth Factor B (VEGFB))
-
Andere Bezeichnung
- VEGFB
-
Hintergrund
-
Background: Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis.
Aliases: Vascular endothelial growth factor B antibody, Vascular endothelial growth factor-related factor antibody, VEGF B antibody, VEGF related factor antibody, VEGF-B antibody, VEGF-related factor antibody, Vegfb antibody, VEGFB_HUMAN antibody, VEGFL antibody, VRF antibody
-
UniProt
- P49765
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Target
-